Stephen Garner
We have observed 59 EP applications Stephen Garner has served for within the last five+ years. (We consider all applications which have an EP A1 or A2 publication dated after December 04, 2014). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:
COMPOSITIONS AND METHODS FOR TRANSMUCOSAL ABSORPTION
- IPC classification:
- A61K 31/135, A61K 9/00
- Agent:
- Stephen Garner, Mathys & Squire LLP
- Status:
- █ GRANT OF PATENT INTENDED
GLUCOSYLCERAMIDE SYNTHASE INHIBITORS
- IPC classification:
- A61K 31/439, C07D 471/08, C07D 453/02, A61P 35/00, A61P 25/00
- Applicant:
- Genzyme Corporation
- Agent:
- Stephen Garner, Mathys & Squire LLP
- Status:
- █ GRANT OF PATENT INTENDED
BIOGLASS WITH GLYCOSAMINOGLYCANS
- IPC classification:
- A61K 33/04, A61K 9/14, A61F 13/00
- Agent:
- Multiple attorneys, Mathys & Squire LLP
- Status:
- █ GRANT OF PATENT INTENDED
COMPOSITIONS AND METHODS FOR TREATING PROTEINOPATHIES
- IPC classification:
- A61K 38/46, A61P 25/28
- Applicant:
- Genzyme Corporation
- Agent:
- Stephen Garner, Mathys & Squire LLP
- Status:
- █ EXAMINATION IN PROGRESS
IL-6 ANTAGONISTS AND USES THEREOF
- IPC classification:
- C07K 16/24, A61P 27/02
- Agent:
- Vossius & Partner Patentanwälte Rechtsanwälte mbB
- Agent:
- Multiple attorneys, Mathys & Squire LLP
- Status:
- █ EXAMINATION IN PROGRESS
BIOACTIVE GLASS WITH ETHYLENE OXIDE PROPYLENE OXIDE BLOCK COPOLYMERS
- IPC classification:
- A61F 2/28
- Agent:
- Multiple attorneys, Mathys & Squire LLP
- Status:
- █ GRANT OF PATENT INTENDED
SOLID COMPOSITIONS
- IPC classification:
- A61K 31/00, A61K 9/20, A61K 9/16, A61K 9/14
- Applicant:
- AbbVie Bahamas Limited
- Agent:
- Stephen Garner, Mathys & Squire LLP
- Agent:
- Micaela Modiano, Modiano & Partners
- Status:
- █ The patent has been granted
SALT FORMS OF (S)-QUINUCLIDIN-3-YL (2-(2-(4-FLUOROPHENYL)THIAZOL-4-YL)PROPAN-2-YL)CARBAMATE
- IPC classification:
- A61P 3/00, A61P 35/00, A61K 31/439, C07D 453/00
- Applicant:
- Genzyme Corporation
- Agent:
- Stephen Garner, Mathys & Squire LLP
- Status:
- █ EXAMINATION IN PROGRESS
PIPERAZINE DERIVATIVES AND THEIR USE AS KIT MODULATORS
- IPC classification:
- A61P 17/00, A61K 31/5377, A61K 31/517, C07D 487/04, C07D 239/94, C07D 409/14, C07D 403/14, C07D 403/04, C07D 401/12, C07D 413/14, C07D 405/14
- Agent:
- Stephen Garner, Mathys & Squire LLP
- Status:
- █ EXAMINATION IN PROGRESS
SODIUM CONTAINING SOL-GEL DERIVED BIOACTIVE GLASSES AND USES THEREOF INCLUDING HEMOSTASIS
- IPC classification:
- C08K 9/06, C03C 3/078
- Agent:
- Multiple attorneys, Mathys & Squire LLP
- Status:
- █ EXAMINATION REQUESTED
CHIMERIC CYTOKINE FORMULATIONS FOR OCULAR DELIVERY
- IPC classification:
- A61K 47/26, A61K 47/10, A61K 9/00, A61K 38/20
- Agent:
- Multiple attorneys, Mathys & Squire LLP
- Status:
- █ EXAMINATION REQUESTED
COMPOSITIONS AND METHODS FOR MANUFACTURING SOL-GEL DERIVED BIOACTIVE BOROPHOSPHATE GLASSES FOR MEDICAL APPLICATONS
- IPC classification:
- C08K 9/06, C03C 3/078
- Agent:
- Multiple attorneys, Mathys & Squire LLP
- Status:
- █ EXAMINATION REQUESTED
METHOD OF PREPARING GLUCOSYLCERAMIDE SYNTHASE INHIBITORS
- IPC classification:
- C07D 277/30, C07D 417/06, C07D 453/02
- Applicant:
- Genzyme Corporation
- Agent:
- Stephen Garner, Mathys & Squire LLP
- Status:
- █ The patent has been granted
ALBUMIN VARIANTS BINDING TO FCRN
- IPC classification:
- G01N 33/50
- Agent:
- Stephen Garner, Mathys & Squire LLP
- Agent:
- Rachel Clare Williams, Novozymes Biopharma UK Limited
- Status:
- █ EXAMINATION IN PROGRESS
PYRIDAZINE DERIVATIVES, COMPOSITIONS AND METHODS FOR TREATING COGNITIVE IMPAIRMENT
- IPC classification:
- A61K 31/50
- Agent:
- Stephen Garner, Mathys & Squire LLP
- Status:
- █ The patent has been granted
COMPOSITIONS USEFUL FOR TREATING DISORDERS RELATED TO KIT
- IPC classification:
- A61K 31/53, A61P 35/00, C07D 487/04
- Agent:
- Stephen Garner, Mathys & Squire LLP
- Status:
- █ The patent has been granted
INHIBITORS OF THE FIBROBLAST GROWTH FACTOR RECEPTOR
- IPC classification:
- A61P 35/00, A61K 31/498, C07D 409/12, C07D 403/14, C07D 405/12, C07D 235/30, C07D 401/12, C07D 401/04, C07D 403/12
- Agent:
- Stephen Garner, Mathys & Squire LLP
- Status:
- █ EXAMINATION REQUESTED
SOLID PHARMACEUTICAL COMPOSITIONS USEFUL IN HCV TREATMENT
- IPC classification:
- A61P 31/22, A61K 31/497, A61K 31/4025, A61K 31/427, A61K 9/20, A61K 9/14, A61K 47/32, A61K 47/22, A61K 47/14, A61K 9/00
- Applicant:
- AbbVie Deutschland GmbH & Co KG
- Agent:
- Stephen Garner, Mathys & Squire LLP
- Agent:
- Micaela Modiano, Modiano & Partners
- Status:
- █ EXAMINATION REQUESTED
GLUCOSYLCERAMIDE SYNTHASE INHIBITORS
- IPC classification:
- A61P 9/00, A61K 31/439
- Applicant:
- Genzyme Corporation
- Agent:
- Stephen Garner, Mathys & Squire LLP
- Status:
- █ EXAMINATION IN PROGRESS
SOLID ANTIVIRAL DOSAGE FORMS
- IPC classification:
- A61P 31/14, A61K 31/513, A61K 31/497, A61K 31/427, A61K 31/4025, A61K 9/24, A61K 47/38, A61K 47/32
- Applicant:
- AbbVie Deutschland GmbH & Co KG
- Agent:
- Stephen Garner, Mathys & Squire LLP
- Agent:
- Micaela Modiano, Modiano & Partners
- Status:
- █ EXAMINATION REQUESTED
SITE-SPECIFIC GLYCOENGINEERING OF TARGETING MOIETIES
- IPC classification:
- C07K 16/40, C07K 16/32, C07K 16/28, A61K 47/60
- Applicant:
- Genzyme Corporation
- Agent:
- Stephen Garner, Mathys & Squire LLP
- Status:
- █ EXAMINATION REQUESTED
CRYSTAL FORMS
- IPC classification:
- A61P 31/14, A61K 38/05, A61K 31/4178, C07D 519/00, C07D 417/14, C07D 413/14, C07D 405/14, C07D 403/14, C07D 401/10, C07D 207/16
- Applicant:
- AbbVie Inc
- Agent:
- Stephen Garner, Mathys & Squire LLP
- Agent:
- Micaela Modiano, Modiano & Partners
- Status:
- █ EXAMINATION REQUESTED
ELIGLUSTAT (GENZ 112638) AS INHIBITOR OF GLUCOSYLCERAMIDE SYNTHASE FOR USE IN A METHOD OF TREATING FABRY'S OR GAUCHER'S DISEASE, THE METHOD COMPRISING ADJUSTING THE INDIVIDUAL THERAPEUTICAL DOSE TO THE P-450 METABOLISM OF THE PATIENT
- IPC classification:
- A61P 35/00, A61K 31/4025, A61K 45/06, C07D 405/06
- Applicant:
- Genzyme Corporation
- Agent:
- Stephen Garner, Mathys & Squire LLP
- Status:
- █ EXAMINATION IN PROGRESS
NAMPT INHIBITORS AND METHODS
- IPC classification:
- A61P 37/06, A61P 35/00, A61P 31/12, A61K 31/537, A61K 31/444, A61K 31/438, C07D 498/10, C07D 491/20, C07D 491/107
- Agent:
- Stephen Garner, Mathys & Squire LLP
- Status:
- █ EXAMINATION REQUESTED
CRYSTAL FORMS
- IPC classification:
- A61K 38/12
- Agent:
- Stephen Garner, Mathys & Squire LLP
- Agent:
- Micaela Modiano, Modiano & Partners
- Status:
- █ EXAMINATION REQUESTED
EUTECTIC FORMULATIONS OF CYCLOBENZAPRINE HYDROCHLORIDE
- IPC classification:
- A61P 21/02, A61K 31/047, A61K 31/135
- Agent:
- Stephen Garner, Mathys & Squire LLP
- Status:
- █ Request for examination was made
METHODS OF TREATING MUCOPOLYSACCHARIDOSIS IIIB (MPSIIIB)
- IPC classification:
- C12N 9/24, A61K 38/47
- Agent:
- Stephen Garner, Mathys & Squire LLP
- Status:
- █ Request for examination was made
LYSOSOMAL STORAGE DISEASE ENZYME
- IPC classification:
- A61K 38/38, C12N 9/20, A61K 31/194, A01K 67/027, A61P 3/06, A61K 31/135, A61K 31/397, A61K 31/366, A61K 38/46
- Agent:
- Stephen Garner, Mathys & Squire LLP
- Status:
- █ The application has been published
CARBIDOPA AND L-DOPA PRODRUGS AND THEIR USE TO TREAT PARKINSON'S DISEASE
- IPC classification:
- A61P 25/16, A61K 31/6615, A61K 31/661
- Applicant:
- AbbVie Inc
- Agent:
- Stephen Garner, Mathys & Squire LLP
- Status:
- █ Request for examination was made
LEVODOPA AND CARBIDOPA INTESTINAL GEL AND METHODS OF USE
- IPC classification:
- A61K 31/198, A61K 31/195, A61K 47/38, A61K 9/10, A61K 9/00
- Applicant:
- AbbVie Inc
- Agent:
- Stephen Garner, Mathys & Squire LLP
- Status:
- █ Request for examination was made
METHODS FOR TREATING PROTEINOPATHIES
- IPC classification:
- A61P 25/28, A61P 25/16, A61K 31/439, A61K 31/00
- Agent:
- Stephen Garner, Mathys & Squire LLP
- Status:
- █ Request for examination was made
BENZODIAZEPINE DERIVATIVES, COMPOSITIONS, AND METHODS FOR TREATING COGNITIVE IMPAIRMENT
- IPC classification:
- A61P 25/00, A61K 31/5513, C07D 487/14
- Agent:
- Stephen Garner, Mathys & Squire LLP
- Status:
- █ Request for examination was made
SOLID PHARMACEUTICAL COMPOSITIONS FOR TREATING HCV
- IPC classification:
- A61P 31/14, A61K 31/498, A61K 31/454, A61K 9/24, A61K 9/20, A61K 9/14
- Applicant:
- AbbVie Inc
- Agent:
- Stephen Garner, Mathys & Squire LLP
- Status:
- █ Request for examination was made
COMPOUNDS USEFUL FOR TREATING DISORDERS RELATED TO KIT AND PDGFR
- IPC classification:
- A61P 35/00, A61K 31/53, C07D 487/04
- Agent:
- Stephen Garner, Mathys & Squire LLP
- Status:
- █ The patent has been granted
SOLID PHARMACEUTICAL COMPOSITIONS FOR TREATING HCV
- IPC classification:
- A61P 31/14, A61K 31/498, A61K 31/454, A61K 9/24, A61K 9/20, A61K 9/14
- Applicant:
- AbbVie Inc
- Agent:
- Stephen Garner, Mathys & Squire LLP
- Status:
- █ Request for examination was made
COMPOUNDS AND COMPOSITIONS USEFUL FOR TREATING DISORDERS RELATED TO NTRK
- IPC classification:
- A61P 35/00, A61K 31/519, C07D 487/04
- Agent:
- Stephen Garner, Mathys & Squire LLP
- Status:
- █ Request for examination was made
ANTI-VIRAL TETRAHYDROFURANE DERIVATIVES
- IPC classification:
- A61K 31/7072, A61P 31/14, C07H 19/06
- Applicant:
- AbbVie Inc
- Agent:
- Stephen Garner, Mathys & Squire LLP
- Status:
- █ Request for examination was made
SOLID PHARMACEUTICAL DOSAGE FORM COMPRISING AN HIV PROTEASE INHIBITOR SOLID DISPERSION
- IPC classification:
- A61K 31/425, A61K 9/20, A61K 9/14
- Applicant:
- AbbVie Inc
- Agent:
- Stephen Garner, Mathys & Squire LLP
- Status:
- █ The application has been published
WNT SIGNALING PATHWAY INHIBITORS AND THERAPEUTIC APPLICATIONS THEREOF
- IPC classification:
- A61P 43/00, A61K 31/444, A61K 31/4725
- Agent:
- Stephen Garner, Mathys & Squire LLP
- Status:
- █ Request for examination was made
INHIBITORS OF RET
- IPC classification:
- A61K 31/4439, A61K 31/506, A61K 31/53, A61P 35/00, C07D 403/14, C07D 401/14
- Agent:
- Stephen Garner, Mathys & Squire LLP
- Status:
- █ Request for examination was made
COMPOUNDS AND COMPOSITIONS USEFUL FOR TREATING DISORDERS RELATED TO NTRK
- IPC classification:
- A61K 31/519, C07D 487/04
- Agent:
- Stephen Garner, Mathys & Squire LLP
- Status:
- █ Request for examination was made
INHIBITORS OF THE FIBROBLAST GROWTH FACTOR RECEPTOR
- IPC classification:
- C07D 475/00, C07D 471/04, C07D 239/84, A61P 35/00, A61K 31/498, C07D 409/12, C07D 403/14, C07D 405/12, C07D 235/30, C07D 401/12, C07D 401/04, C07D 403/12
- Agent:
- Stephen Garner, Mathys & Squire LLP
- Status:
- █ Request for examination was made
LEVETIRACETAM FOR IMPROVING COGNITIVE FUNCTION
- IPC classification:
- A61P 25/08, A61P 25/28, A61K 31/4015, A61K 31/20
- Applicant:
- Johns Hopkins University
- Agent:
- Stephen Garner, Mathys & Squire LLP
- Status:
- █ Request for examination was made
COMPOSITIONS USEFUL FOR TREATING DISORDERS RELATED TO KIT
- IPC classification:
- A61K 31/53, A61P 35/00, C07D 487/04
- Agent:
- Stephen Garner, Mathys & Squire LLP
- Status:
- █ Request for examination was made
INHIBITORS OF ACTIVIN RECEPTOR-LIKE KINASE
- IPC classification:
- A61P 19/00, A61K 31/5025, C07D 519/00, C07D 487/04
- Agent:
- Stephen Garner, Mathys & Squire LLP
- Status:
- █ Request for examination was made
CARBIDOPA AND L-DOPA PRODRUGS AND METHODS OF USE
- IPC classification:
- A61P 25/16, A61K 31/7012, A61K 31/661, A61K 31/4468, A61K 31/10, A61K 31/05
- Applicant:
- AbbVie Inc
- Agent:
- Stephen Garner, Mathys & Squire LLP
- Status:
- █ Request for examination was made
CRYSTALLINE POLYMORPHS OF OMBITASVIR
- IPC classification:
- A61P 31/14, A61K 31/4025, C07D 403/14
- Applicant:
- AbbVie Inc
- Agent:
- Stephen Garner, Mathys & Squire LLP
- Status:
- █ Request for examination was made
SOLID COMPOSITIONS
- IPC classification:
- A61K 31/00, A61K 9/20, A61K 9/16, A61K 9/14
- Agent:
- Stephen Garner, Mathys & Squire LLP
- Status:
- █ Request for examination was made
LYSOSOMAL ACID LIPASE DEFICIENCY COMPOSITIONS AND METHODS
- IPC classification:
- A61K 38/46, C12N 9/20, C12Q 1/68
- Agent:
- Stephen Garner, Mathys & Squire LLP
- Status:
- █ Request for examination was made
METHODS OF TREATING OVARIAN CANCER
- IPC classification:
- C12Q 1/68, A61K 31/4745, A61K 31/454
- Agent:
- Stephen Garner, Mathys & Squire LLP
- Status:
- █ Request for examination was made
A SOLID PHARMACEUTICAL DOSAGE FORMULATION COMPRISING LOPINAVIR
- IPC classification:
- A61P 31/18, A61K 9/28, A61K 9/20, A61K 31/426, A61K 31/513
- Applicant:
- AbbVie Inc
- Agent:
- Stephen Garner, Mathys & Squire LLP
- Status:
- █ The application has been published
LEVODOPA AND CARBIDOPA INTESTINAL GEL AND METHODS OF USE
- IPC classification:
- A61P 25/16, A61K 31/198, A61K 31/195, A61K 47/38, A61K 47/32, A61K 47/10, A61K 9/00
- Applicant:
- AbbVie Inc
- Agent:
- Stephen Garner, Mathys & Squire LLP
- Status:
- █ Request for examination was made
METHOD OF PREPARING GLUCOSYLCERAMIDE SYNTHASE INHIBITORS
- IPC classification:
- C07D 277/30, C07D 417/06, C07D 453/02
- Agent:
- Stephen Garner, Mathys & Squire LLP
- Status:
- █ The application has been published
DOSE ADJUSTMENT
- IPC classification:
- C07D 403/10, A61P 31/14, A61K 31/4184, A61K 31/4709
- Applicant:
- AbbVie Inc
- Agent:
- Stephen Garner, Mathys & Squire LLP
- Status:
- █ Request for examination was made
SYNTHETIC CHIMERIC POXVIRUSES
- IPC classification:
- A61K 39/275, C12N 7/01
- Agent:
- Stephen Garner, Mathys & Squire LLP
- Status:
- █ Request for examination was made
NOVEL MODULATORS OF THE 5-HYDROXYTRYPTAMINE RECEPTOR 7 AND THEIR METHOD OF USE
- IPC classification:
- C07D 307/94, C07D 307/33
- Applicant:
- Temple University of the Commonwealth System of Higher Education
- Agent:
- Stephen Garner, Mathys & Squire LLP
- Status:
- █ Request for examination was made
TIANEPTINE OXALATE SALTS AND POLYMORPHS
- IPC classification:
- A61K 31/554, C07D 281/02
- Agent:
- Stephen Garner, Mathys & Squire LLP
- Status:
- █ Request for examination was made
INTERMEDIATES AND PROCESS FOR PREPARING L-DOPA DIPHOSPHATE
- IPC classification:
- A61P 25/16, A61K 31/6615, A61K 31/661, C07F 9/09, C07C 309/24, C07C 281/02, C07C 47/277
- Applicant:
- AbbVie Inc
- Agent:
- Stephen Garner, Mathys & Squire LLP
- Status:
- █ The application has been published
BENZODIAZEPINE DERIVATIVES, COMPOSITIONS, AND METHODS FOR TREATING COGNITIVE IMPAIRMENT
- IPC classification:
- A61P 35/00, A61P 25/00, A61K 31/5517, C07D 487/14
- Agent:
- Stephen Garner, Mathys & Squire LLP
- Status:
- █ Request for examination was made